BioHealth News Archive
Johns Hopkins COVID-19 dashboard provides ‘exhaustive information’ to clinicians
Johns Hopkins University launched its popular COVID-19 map on Jan. 22 — just 2 days after the first person in the United States was…
Read More
BioBuzz Awards (VOTE NOW)· BioBuzz
This year, more than ever before, we’ve seen just how important it is for us all to stay connected and work together to build…
Read More
Exact Sciences Eyes Cancer Dx Leadership with Up to $2.5B in Deals for Thrive, Base Genomics
Exact Sciences said today it has agreed to a pair of acquisitions designed to create a diagnostics powerhouse across multiple cancers. In the larger…
Read More
“Somewhere past the pandemic” celebrates the 30-year partnership between The National Institutes of Health and The Children’s Inn
“Somewhere past the pandemic” celebrates the 30-year partnership between The National Institutes of Health and The Children's Inn in caring for the children and…
Read More
DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats | Global Biodefense
The rapid availability of effective medical countermeasures against chemical exposures, from either accidents or chemical weapons attack, is critical in the treatment of their…
Read More
SBIR Funding Proposals Due to NIH by January 5, 2021: 5 Tips for Your Submission | PilieroMazza PLLC – JDSupra
The Small Business Innovative Research (SBIR) program provides grant or contract funding to small businesses seeking to commercialize innovative technologies. With $3.2 billion allotted…
Read More
Novavax to Provide 40 Million Doses of Its COVID-19 Vaccine Candidate to Australia | The Motley Fool
Novavax (NASDAQ:NVAX) announced on Wednesday that it has reached an agreement to provide the Australian government with 40 million doses of its COVID-19 vaccine candidate,…
Read More
Novavax Announces Facility Expansion to Support Global Vaccine Development | Novavax Inc. – IR Site
GAITHERSBURG, Md., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced…
Read More
What Floreo’s expansion into ADHD means for the autism-focused virtual reality startup – Washington Business Journal
Through a partnership with NIH, D.C. virtual reality startup Floreo is expanding from autism spectrum disorder to attention deficit hyperactivity disorder. Image: Floreo's platform…
Read More
Jaan Biotherapeutics Awarded NIH Grant to Advance Cardiac Muscle Regeneration Therapy – MarketWatch
Sep 05, 2020 (IssueWire via COMTEX) -- San Diego, Sep 5, 2020 (Issuewire.com) - Jaan Biotherapeutics ("JBT"), announced that it has been awarded a…
Read More
Rexahn Pharmaceuticals Announces Stockholder Approval of All Proposals Required for Merger with Ocuphire Pharma :: Rexahn Pharmaceuticals, Inc. (REXN)
ROCKVILLE, Md., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NASDAQ:REXN) (“Rexahn”) announced today that at its special meeting of stockholders held on…
Read More
Neuraly Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 2B Trial of NLY01 for Patients with Alzheimer’s Disease | Business Wire
GAITHERSBURG, Md.--(BUSINESS WIRE)--Neuraly, Inc., a clinical stage biotechnology company pioneering disease-modifying agents for neurodegenerative disorders, today announced it has received clearance of an investigational…
Read More
Emmes Employees Co-Author COVID-19 Vaccine Report for the New England Journal of Medicine | BioSpace
Three Emmes employees were among the co-authors of the recent report, "Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults." The employees are…
Read More
JHU Spinout Thrive Earlier Detection Lands up to $2.15 Billion in Acquisition by Exact Sciences · BioBuzz
MADISON, Wis. and CAMBRIDGE, Mass., Oct. 27, 2020 /PRNewswire/ — Exact Sciences Corp. (Nasdaq: EXAS) and Thrive Earlier Detection Corp. (“Thrive”), a healthcare company dedicated to incorporating earlier…
Read More
REGENXBIO to Receive $80.0 Million Milestone Payment from Novartis AG | REGENXBIO Inc.
ROCKVILLE, Md., Oct. 27, 2020 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential…
Read More